| Oct 30 |
PureTech to Present at Two Upcoming Investor Conferences
|
| Oct 21 |
PureTech thinks the ‘hub-and-spoke’ startup model is still a good bet. If only investors agreed.
|
| Oct 21 |
PureTech Founded Entity Seaport Therapeutics Closes $225 Million Oversubscribed Series B Financing Round
|
| Oct 9 |
Corrections & Amplifications
|
| Oct 9 |
PureTech Presents Research Highlighting Burden of Idiopathic Pulmonary Fibrosis (IPF) and Use of a Bayesian Statistical Analysis for LYT-100 (Deupirfenidone) at CHEST 2024 Annual Meeting
|
| Oct 1 |
PureTech to Present at CHEST 2024 Annual Meeting
|
| Sep 30 |
FDA approves PureTech’s KarXT to treat schizophrenia in adults
|
| Sep 27 |
PureTech-Invented KarXT Receives U.S. Food and Drug Administration Approval for the Treatment of Schizophrenia in Adults
|
| Sep 6 |
PureTech Founded Entity Vor Bio Announces New Clinical Data Validating Approach of Using Shielded Transplants to Deliver Targeted Therapies
|
| Sep 3 |
Boeing, Dyne Therapeutics And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
|
